COMPLETED

Peripheral Immune System in Individuals With Schizophrenia

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators are seeking healthy volunteers and people with schizophrenia or schizoaffective disorder for a clinical study of the immune system in psychotic disorders. This is an observational study, to understand the ways in which the immune system may be contributing to the disease process.

Official Title

Peripheral Immune System in Individuals With Schizophrenia

Quick Facts

Study Start:2021-03-01
Study Completion:2024-05-23
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05109065

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 40 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Agnieszka Kalinowski, MD PhD
PRINCIPAL_INVESTIGATOR
Clinical Assistant Professor

Study Locations (Sites)

Stanford University School of Medicine
Stanford, California, 94704
United States

Collaborators and Investigators

Sponsor: Stanford University

  • Agnieszka Kalinowski, MD PhD, PRINCIPAL_INVESTIGATOR, Clinical Assistant Professor

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-03-01
Study Completion Date2024-05-23

Study Record Updates

Study Start Date2021-03-01
Study Completion Date2024-05-23

Terms related to this study

Keywords Provided by Researchers

  • psychosis
  • psychiatry
  • complement immune system

Additional Relevant MeSH Terms

  • Schizophrenia
  • Schizo Affective Disorder
  • Schizophreniform Disorders